135 related articles for article (PubMed ID: 15480261)
1. [Infiltrating lobular carcinoma of the breast with histiocytoid features: three cases].
Augros M; Buénerd A; Devouassoux-Shisheboran M; Berger G
Ann Pathol; 2004 Jun; 24(3):259-63; quiz 227. PubMed ID: 15480261
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast.
Gupta D; Croitoru CM; Ayala AG; Sahin AA; Middleton LP
Ann Diagn Pathol; 2002 Jun; 6(3):141-7. PubMed ID: 12089723
[TBL] [Abstract][Full Text] [Related]
3. Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic, and ultrastructural study.
Eusebi V; Betts C; Haagensen DE; Gugliotta P; Bussolati G; Azzopardi JG
Hum Pathol; 1984 Feb; 15(2):134-40. PubMed ID: 6365733
[TBL] [Abstract][Full Text] [Related]
4. Histiocytoid breast carcinoma: histological, immunohistochemical, ultrastructural, cytological and clinicopathological studies.
Shimizu S; Kitamura H; Ito T; Nakamura T; Fujisawa J; Matsukawa H
Pathol Int; 1998 Jul; 48(7):549-56. PubMed ID: 9701019
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue.
Satoh F; Umemura S; Osamura RY
Breast Cancer; 2000 Jan; 7(1):49-55. PubMed ID: 11029771
[TBL] [Abstract][Full Text] [Related]
6. Primary signet ring cell carcinoma of the eyelid: report of a case demonstrating further analogy to lobular carcinoma of the breast with a literature review.
Langel DJ; Yeatts RP; White WL
Am J Dermatopathol; 2001 Oct; 23(5):444-9. PubMed ID: 11801778
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
Radhi JM
Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
[TBL] [Abstract][Full Text] [Related]
8. Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases.
Bentz JS; Yassa N; Clayton F
Mod Pathol; 1998 Sep; 11(9):814-22. PubMed ID: 9758360
[TBL] [Abstract][Full Text] [Related]
9. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study.
Raju U; Ma CK; Shaw A
Mod Pathol; 1993 Sep; 6(5):516-20. PubMed ID: 8248106
[TBL] [Abstract][Full Text] [Related]
10. Cytology of pleomorphic lobular carcinoma with apocrine cell differentiation of the breast. A case report.
Tashiro T; Hirokawa M; Iuchi K; Emoto K; Tanaka T; Monobe Y; Sano T
Acta Cytol; 2003; 47(2):265-9. PubMed ID: 12685199
[TBL] [Abstract][Full Text] [Related]
11. Differential sensitivity of estrogen/progesterone receptors and BRST-2 markers in metastatic ductal and lobular breast carcinoma to the skin.
Wallace ML; Smoller BR
Am J Dermatopathol; 1996 Jun; 18(3):241-7. PubMed ID: 8806958
[TBL] [Abstract][Full Text] [Related]
12. Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas.
Frolik D; Caduff R; Varga Z
Histopathology; 2001 Nov; 39(5):503-13. PubMed ID: 11737309
[TBL] [Abstract][Full Text] [Related]
13. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
[TBL] [Abstract][Full Text] [Related]
14. Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors.
Mazoujian G; Bodian C; Haagensen DE; Haagensen CD
Cancer; 1989 Jun; 63(11):2156-61. PubMed ID: 2655863
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and progesterone receptors in breast cancer.
Couch P
Am J Dermatopathol; 1997 Oct; 19(5):553-5. PubMed ID: 9335253
[No Abstract] [Full Text] [Related]
16. Expression of aberrant mucins in lobular carcinoma with histiocytoid feature of the breast.
Kasashima S; Kawashima A; Zen Y; Ozaki S; Kobayashi M; Tsujibata A; Minato H
Virchows Arch; 2007 Apr; 450(4):397-403. PubMed ID: 17333267
[TBL] [Abstract][Full Text] [Related]
17. The apocrine carcinoma of the breast. A cytological, immunohistochemical and ultrastructural study of 6 cases.
Alexiev B; Boschnakova Z; Prokopanov C
Zentralbl Pathol; 1994 Jul; 140(2):129-34. PubMed ID: 7524651
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of gross cystic disease fluid protein-15, -24 and -44 in ductal carcinoma in situ of the breast: relationship to the degree of differentiation.
Selim AA; El-Ayat G; Wells CA
Histopathology; 2001 Aug; 39(2):198-202. PubMed ID: 11493337
[TBL] [Abstract][Full Text] [Related]
19. Histiocytoid change in breast carcinoma: a report of 3 cases with an unusual cytomorphologic pattern of apocrine change.
Murali R; Salisbury E; Pathmanathan N
Acta Cytol; 2006; 50(5):548-52. PubMed ID: 17017444
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation.
Ansai S; Koseki S; Hozumi Y; Kondo S
Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]